RAS is activated by a complex signal cascade and, in turn, triggers downstream signalling pathways, such as the PI3 K/AKT, MAPK and Ral pathways, associated with uncontrolled cell proliferation and tumour growth [40,41]. The gene discussed is RALA; the disease is neoplasm.